Contact Us

CLONGENEBIOProfessional CRO/CDMO services for global biopharmaceutical field

ClongeneBio is a technology-based enterprise that provides professional CRO/CDMO services for the global biopharmaceutical field. Based on the 10000+m² GMP production workshop and mature R&D center, as well as the accumulated rich technical experience and advanced technology platform, we can provide customers with antibody discovery, antibody expression, protein sequencing, gene editing, protein expression, and stable cell line development services. Our services cover the links from early stage R&D, gene synthesis, cell line development, production process development, bioassay analysis to large-scale commercial production.

Services & Solutions More

Protein Expression Services

E.coli Protein Expression

Baculovirus-Insect Cell Protein Expression 

Mammalian Transient Protein Expression 

Antibody Discovery Services

Beacon Single B Cell Screening
Hybridoma Monoclonal Antibody development

Antibody Expression Services

High-throughput Antibody Production 

Large-scale Antibody Production 

Cell Line Development

CHO-K1 Cell Line Development

CHO-GS Cell Line Development

Protein Sequencing

Protein sequencing
Monoclonal antibody sequencing
Polyclonal antibody sequencing


Gene Editing Service

Alternate Text Protein Expression Services
Alternate Text Antibody Discovery Services
Alternate Text Antibody Expression Services
Alternate Text Cell Line Development
Alternate Text Protein Sequencing
Alternate Text CRISPR/Cas9

Efficient services
Easy development

ClongeneBio services mainly focus on basic scientific research, protein and antibody engineering, cell line development, production process development, bioassay analysis.

One-stop customized services from antigen design to antibody production.

Achieve multiple projects at the same time to meet the different needs of customers.

Strong guarantee for the development and analysis of recombinant proteins, antibodies and cells.

A variety of advanced instruments and equipment and professional technical personnel.

News More
Feb. 22, 2024
Nov. 01, 2023

Mission and Vision

Technological innovation, service first
Become the premier accelerator in the field of biomedicine of the world